Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver

Author:

Li Wei-Feng1,Liu Yueh-Wei1,Wang Chih-Chi1,Yong Chee-Chien1,Lin Chih-Che1,Yen Yi-Hao1

Affiliation:

1. Kaohsiung Chang Gung Memorial Hospital

Abstract

Abstract Purpose:The Barcelona Clinic Liver Cancer (BCLC) staging system has been recommended for prognostic prediction. However, prognosis is variable at different BCLC stages. We aimed to evaluate whether the radiographic tumor burden score (TBS) could be used to stratify prognosis in different BCLC stages. Methods: Hepatocellular carcinoma (HCC) patients undergoing liver resection (LR) at BCLC-0, -A, or -B stage in our institution in 2007–2018 were divided into derivation and validation cohorts. Overall survival (OS) was analyzed according to the TBS and BCLC stage. TBS cutoff values for OS were determined with X-tile. Results: Of the 749 patients in the derivation cohort, 138 (18.4%) had BCLC-0, 542 (72.3 %) BCLC-A, and 69 (9.2 %) BCLC-B HCC; 81 (10.8%) had a high TBS (> 7.9), 474 (63.3%) a medium TBS (2.6–7.9), and 194 (25.9%) a low TBS (< 2.6). OS worsened progressively with increasing TBS in the cohort (p< 0.001) and in BCLC-A (p = 0.04) and BCLC-B (p = 0.002) stages. Multivariate analysis showed that the TBS was associated with OS of patients with BCLC-A (medium vs. low TBS: hazard ratio [HR] = 2.390, 95% CI = 1.024–5.581, p = 0.04; high vs. low TBS: HR = 3.885, 95% CI =1.443–10.456, p = 0.007) and BCLC-B (high vs. medium TBS: HR = 2.542, 95% CI = 1.077–6.002, p = 0.033) HCC. The TBS could also be used to stratify the OS of patients in the validation cohort (p< 0.001). Conclusion: The TBS could be used to stratify the OS of the entire cohort and BCLC stages A and B of HCC patients undergoing LR.

Publisher

Research Square Platform LLC

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3